When AI Goes Public: What OpenAI and Anthropic's IPOs Mean

AI meets the public market

For a decade, the most consequential technology of the era has been financed almost entirely in private. OpenAI and Anthropic raised hundreds of billions from a small circle of venture funds, sovereign wealth vehicles and cloud providers, disclosed roughly what they chose to disclose, and answered to boards built to insulate them from exactly the pressure public markets exist to apply.

That is ending. Anthropic confidentially filed a draft S-1 with the SEC on 1 June 2026; OpenAI followed a week later. Anthropic is meeting investors ahead of a listing that could launch as soon as October, with Goldman Sachs, Morgan Stanley and JPMorgan leading; OpenAI is reportedly leaning toward 2027. Neither has confirmed a date or a price, and because the filings are confidential, the figures in circulation remain investor estimates rather than audited fact.

The question worth answering carefully: what changes when the companies building frontier AI answer not only to founders, employees and private investors, but to public shareholders?

What makes these two different

Plenty of companies go public. Very few go public looking like these.

The capital requirements are unprecedented. In November 2025 Sam Altman put OpenAI's data-centre commitments at about $1.4 trillion over eight years; by February 2026 the company was telling investors it was targeting roughly $600 billion in total compute spend by 2030 — against $13.1 billion of revenue in 2025. Anthropic raised $65 billion in a single round in May and has expanded compute partnerships with Google and Broadcom. Neither can fund its roadmap from operating cash flow. That, more than any change of philosophy, is why they are listing: private capital, deep as it has become, is running out of room.

So is the growth. Anthropic reported an annualised run rate around $47 billion in May 2026, up from roughly $9 billion at the end of 2025, and reportedly above $65 billion by the end of July. OpenAI ended 2025 above $20 billion annualised, with more than 800 million weekly ChatGPT users. One caveat belongs beside every one of these numbers: a run rate annualises a single recent month. It measures momentum, not money banked. Anthropic has not earned $47 billion in a year — it was selling at that speed in May.

The governance is genuinely strange. Anthropic is a Delaware public benefit corporation whose Long-Term Benefit Trust — three financially disinterested trustees holding non-economic shares, down from four this month after one joined the company's own executive team — has the escalating right to elect a majority of its seven-member board. OpenAI restructured in October 2025 into OpenAI Group PBC, controlled by the OpenAI Foundation, which holds about 26% of the equity but appoints the entire board. In both cases, the people with the votes are not the people with the money.

And both are entangled with the state and the largest firms in the world. Microsoft, Amazon, Nvidia, SoftBank and Google sit on one or both cap tables. Both negotiate directly with governments over export controls and procurement. Both have published binding-sounding commitments about handling dangerous capabilities. None of this is normal for a technology listing, and all of it has to be written into a prospectus as risk.

What changes for the companies

Capital, obviously: stock becomes a currency for compute, acquisitions and talent, and the debt markets open on better terms.

Transparency is the underrated change. Quarterly reporting will settle things that have been guessed at for years — real inference margins, training costs, customer concentration, the terms of the cloud deals, how much growth comes from coding tools. Analysts and short sellers will be paid to find the weak points. The AI debate has run largely on self-reported figures; that ends.

Pressure is the uncomfortable one. Public shareholders punish missed guidance and have little patience for research that does not visibly convert into revenue. A private board can absorb a bad quarter caused by a safety decision. A public one has to explain it, in writing, to people who can sell.

What changes for consumers

Two forces will pull on the price you pay. Scale and cheaper capital push it down: better hardware utilisation and competition between two listed rivals with visible margins should keep driving the cost of a unit of intelligence lower. The demand for profitability pushes the other way. Frontier models are expensive to serve, and the best ones carry a premium: Anthropic lists its flagship at $10 per million input tokens and $50 per million output, against $5 and $30 for OpenAI's — twice the price on input, roughly 1.7 times on output. Companies under margin scrutiny raise prices on power users, tighten free tiers, and hunt for revenue that does not scale with inference cost. Advertising is the standard answer, and that lever has already been pulled: ChatGPT began showing ads to US free-tier users in February 2026 and expanded to five more countries in August, before the company has sold a single public share. Public investors modelling lifetime value per account will want it pulled harder.

The subtler risk is to the product itself. Shipping cadence becomes a signal to the market, and when a rival's launch moves your stock, holding a model back for another month of evaluations gets harder to argue for internally — not because anyone abandons their principles, but because the cost of caution becomes visible and quarterly while its benefits stay invisible and long-term.

What shareholders are betting on

Investors reportedly discussing a $2 trillion valuation for Anthropic — roughly double its $965 billion private mark from May, and enough to make it the largest IPO in history — are underwriting six distinct propositions. It is worth separating them, because they fail in different ways.

Demand. That appetite for AI keeps expanding at close to the current rate, rather than saturating once the easy use cases — coding, drafting, summarising — are served.

Revenue. That sales catch up with the price. Investors told the Financial Times they expect $100–120 billion annualised by December — so at $2 trillion, a buyer is paying roughly seventeen times a revenue level the company has not yet reached. One backer argued that growth of that speed justifies thirty times revenue, which would imply more than $3 trillion. A year's delay costs real money even if the destination is right.

Unit economics. That the cost of serving a query falls faster than the capability frontier raises it. This is the quiet one: every prior generation of models got cheaper to run, but each new generation also demanded more compute, and the margin depends on which curve wins.

Competition. That neither open-weight models nor the hyperscalers' in-house labs turn frontier capability into a commodity. Both companies sell something a customer can switch away from in an afternoon.

Leadership. That today's leaders are still leaders two model generations out — a bet on sustained research advantage in a field where the technical lead has changed hands repeatedly.

Regulation. That whatever rules arrive do not materially restrict how the models can be sold, to whom, or in which markets.

None is guaranteed, and they are correlated — the scenarios where one fails are usually scenarios where several do. The cautionary example is recent: SpaceX priced at $135 a share on 12 June 2026, touched $225 four days later on a thin float, and now trades below its issue price after a post-earnings selloff and the first expiry of insider lockups. Public markets are not only a source of capital. They are a mechanism for finding out what a company is actually worth, and the answer can arrive fast.

Public sentiment

The timing is awkward. American attitudes have hardened: Bentley-Gallup's 2026 survey found 47% of adults aged 18–29 saying AI does more harm than good, up eleven points in a year; an NBC News poll in March put favourable views of AI at 26% of voters; an August CNBC/Generation Labs survey found large majorities of 18-to-34-year-olds distrusting the leaders of major AI companies. More than three in five Americans now oppose data centres being built near them.

For a listed company, sentiment is not a mood — it is a set of prices. Local opposition slows the permits and raises the cost of the data centres the entire capital plan depends on, and delay there is the most direct route from public feeling to a missed number. Two-thirds of Americans say the government has done too little to regulate AI, which is the political precondition for rules that constrain monetisation. Enterprise buyers, who supply most of the revenue, are sensitive to reputational risk in a way retail users are not. And a technology polling below most politicians is a cheap target in an election year. Public equity converts all of this into a discount: a higher risk premium, a lower multiple, a stock that moves on protest coverage.

The listing itself does not help. It reclassifies the labs, publicly and permanently, from research organisations with commercial arms into commercial organisations with research arms. Every safety commitment will now be read against a share price.

The governance problem

Neither company has resolved the central tension: they want public capital without ordinary public-company control.

Anthropic intends to preserve the Trust's power to appoint a majority of its board, and has reportedly weighed super-voting shares for its co-founders as well; Dario Amodei is said to hold around 2% of the company economically. OpenAI's Foundation appoints its entire board while holding roughly a quarter of the equity — an arrangement that took almost a year to negotiate with the California and Delaware attorneys general, both of whom extracted commitments before signing off.

Dual-class structures are old news in tech. But the usual version hands control to founders holding large economic stakes, who therefore share the shareholders' basic interest in the share price. A financially disinterested trust is a different animal: it is designed not to care what the stock does. And Anthropic's version escalates over exactly the period when shareholder pressure intensifies. Read it as the strongest available guarantee that the mission survives contact with the market, or as an unpriceable risk investors are asked to accept without recourse. Both readings are defensible; the valuation will land between them.

Conclusion

Whatever the timing, these listings mark the point at which frontier AI stops being financed as a private technological experiment and starts being continuously valued as a public economic asset — repriced daily, dissected quarterly, held in index funds alongside utilities and banks.

Which leaves two questions, and they will take years to answer. The first is whether public ownership makes these companies more accountable, or merely makes their commercial motivations legible — whether disclosure is a constraint or just a clearer window onto something that was always there.

The second follows from it. Will public ownership discipline the AI laboratories, forcing out the real numbers and subjecting extraordinary claims to the ordinary test of whether anyone will pay for them? Or will the demands of public markets reshape the laboratories instead, until the commitments survive on paper and the incentives run the other way?